참고문헌
- Afonso, M.B., Rodrigues, P.M., Carvalho, T., Caridade, M., Borralho, P., Cortez-Pinto, H., Castro, R.E., and Rodrigues, C.M. (2015). Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin. Sci. 129, 721-739. https://doi.org/10.1042/CS20140732
- Arshad, M.I., Piquet-Pellorce, C., Filliol, A., L'Helgoualc'h, A., Lucas-Clerc, C., Jouan-Lanhouet, S., Dimanche-Boitrel, M.T., and Samson, M. (2015). The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver. J. Mol. Med. 93, 867-878. https://doi.org/10.1007/s00109-015-1270-6
- Cho, Y.S. (2014). Perspectives on the therapeutic modulation of an alternative cell death, programmed necrosis (review). Int. J. Mol. Med. 33, 1401-1406. https://doi.org/10.3892/ijmm.2014.1716
- Cho, Y.S., and Park, H.L. (2017). Exploitation of necroptosis for treatment of caspase-compromised cancers. Oncol. Lett. 14, 1207-1214. https://doi.org/10.3892/ol.2017.6285
- Dasarathy, S. (2012). Consilience in sarcopenia of cirrhosis. J. Cachexia, Sarcopenia Muscle 3, 225-237. https://doi.org/10.1007/s13539-012-0069-3
- Dienstag, J.L., and Cosimi, A.B. (2012). Liver transplantation--a vision realized. N. Eng. J. Med. 367, 1483-1485. https://doi.org/10.1056/NEJMp1210159
- Hannoun, Z., Steichen, C., Dianat, N., Weber, A., and Dubart-Kupperschmitt, A. (2016). The potential of induced pluripotent stem cell derived hepatocytes. J. Hepatol. 65, 182-199. https://doi.org/10.1016/j.jhep.2016.02.025
- Ho, C.M., Lee, P.H., Cheng, W.T., Hu, R.H., Wu, Y.M., and Ho, M.C. (2016). Succinct guide to liver transplantation for medical students. Ann. Med. Surg. 12, 47-53. https://doi.org/10.1016/j.amsu.2016.11.004
- Hussein, K.H., Park, K.M., Kang, K.S., and Woo, H.M. (2016). Heparin-gelatin mixture improves vascular reconstruction efficiency and hepatic function in bioengineered livers. Acta Biomater. 38, 82-93. https://doi.org/10.1016/j.actbio.2016.04.042
- Kang, K., Kim, Y., Lee, S.B., Kim, J.S., Park, S., Kim, W.D., Yang, H.M., Kim, S.J., Jeong, J., and Choi, D. (2017). Three-dimensional bioprinting of hepatic structures with direct-converted hepatocyte-like cells. Tissue Engineering. Part A.
- Kim, S.J., and Lee, S.M. (2017). Necrostatin-1 Protects Against DGalactosamine and Lipopolysaccharide-Induced Hepatic Injury by Preventing TLR4 and RAGE Signaling. Inflammation 40, 1912-1923. https://doi.org/10.1007/s10753-017-0632-3
- Leberfinger, A.N., Ravnic, D.J., Dhawan, A., and Ozbolat, I.T. (2017). Concise review: bioprinting of stem cells for transplantable tissue fabrication. Stem Cells Transl. Med. 6, 1940-1948. https://doi.org/10.1002/sctm.17-0148
- Li, S., Guo, J., Ying, Z., Chen, S., Yang, L., Chen, K., Long, Q., Qin, D., Pei, D., and Liu, X. (2015). Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-dependent apoptotic sensitivity in an induced pluripotent stem cell model. Hepatology 61, 1730-1739. https://doi.org/10.1002/hep.27712
- Luo, Y., Lou, C., Zhang, S., Zhu, Z., Xing, Q., Wang, P., Liu, T., Liu, H., Li, C., Shi, W., et al. (2017). Three-dimensional hydrogel culture conditions promote the differentiation of human induced pluripotent stem cells into hepatocytes. Cytotherapy 20, 95-107.
- Masuoka, H.C., Guicciardi, M.E., and Gores, G.J. (2009). Caspase inhibitors for the treatment of hepatitis C. Clin. Liver Dis. 13, 467-475. https://doi.org/10.1016/j.cld.2009.05.010
- Park, K.M., Hussein, K.H., Hong, S.H., Ahn, C., Yang, S.R., Park, S.M., Kweon, O.K., Kim, B.M., and Woo, H.M. (2016). Decellularized liver extracellular matrix as promising tools for transplantable bioengineered liver promotes hepatic lineage commitments of induced pluripotent stem cells. Tissue Eng. Part A 22, 449-460. https://doi.org/10.1089/ten.tea.2015.0313
- Sakiyama, R., Blau, B.J., and Miki, T. (2017). Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. World J. Gastroenterol. 23, 1974-1979. https://doi.org/10.3748/wjg.v23.i11.1974
- Seo, M.J., Hong, J.M., Kim, S.J., and Lee, S.M. (2017). Genipin protects d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling. Eur. J. Pharmacol. 812, 128-137. https://doi.org/10.1016/j.ejphar.2017.07.024
- Takemoto, K., Hatano, E., Iwaisako, K., Takeiri, M., Noma, N., Ohmae, S., Toriguchi, K., Tanabe, K., Tanaka, H., Seo, S., et al. (2014). Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS Open Bio. 4, 777-787. https://doi.org/10.1016/j.fob.2014.08.007
- Wang, B., Jakus, A.E., Baptista, P.M., Soker, S., Soto-Gutierrez, A., Abecassis, M.M., Shah, R.N., and Wertheim, J.A. (2016). Functional maturation of induced pluripotent stem cell hepatocytes in extracellular matrix-A comparative analysis of bioartificial liver microenvironments. Stem Cell Transl. Med. 5, 1257-1267. https://doi.org/10.5966/sctm.2015-0235
- Wang, Y., Nicolas, C.T., Chen, H.S., Ross, J.J., De Lorenzo, S.B., and Nyberg, S.L. (2017). Recent advances in decellularization and recellularization for tissue-engineered liver grafts. Cells Tissues Organs 204, 125-136. https://doi.org/10.1159/000479597
- Zarrinpar, A., and Busuttil, R.W. (2013). Liver transplantation: past, present and future. Nat. Rev. Gastroenterol. Hepatol. 10, 434-440. https://doi.org/10.1038/nrgastro.2013.88
피인용 문헌
- Experimental Applications of in situ Liver Perfusion Machinery for the Study of Liver Disease vol.42, pp.1, 2018, https://doi.org/10.14348/molcells.2018.0330
- Guidelines for evaluating myocardial cell death vol.317, pp.5, 2018, https://doi.org/10.1152/ajpheart.00259.2019